Abstract Neurodegenerative diseases (NDs), including Alzheimer's disease (AD),
Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS), exhibit high phenotypic …

As aging societies in the western world face a growing prevalence of vascular cognitive
impairment and Alzheimer's disease (AD), understanding their underlying causes and …

Purpose Recent technological advancements in data acquisition tools allowed
neuroscientists to acquire different modality data to diagnosis Alzheimer's disease (AD) …

Abstract Alzheimer's disease (AD), affecting nearly 6.5 million people, is the fifth leading
cause of death in individuals 65 years or older in the USA. Prior research has shown that AD …

Functional magnetic resonance imaging research employing regional homogeneity (ReHo)
analysis has uncovered aberrant local brain connectivity in individuals with mild cognitive …

The mild cognitive impairment (MCI) and dementia in rural areas are increasingly attracting
public attention. However, their prevalence is still unclear. This study aims to reveal the …

As of 2023, it is estimated that 6.7 million individuals in the United States live with
Alzheimer's disease (AD). Prior research indicates that AD disproportionality affects females; …

Diet-induced obesity is implicated in the development of a variety of neurodegenerative
disorders. Concurrently, the loss of mitochondrial Complex I protein or function is emerging …

Graph neural networks (GNNs) are proficient machine learning models in handling
irregularly structured data. Nevertheless, their generic formulation falls short when applied to …

Mounting evidence indicates that the female sex is a risk factor for Alzheimer's disease (AD),
the most common cause of dementia worldwide. Decades of research suggest that sex …